Noticias sobre Fara Brasó-Maristany | Hospital Clínic Barcelona

Clínic Barcelona

Institutional February 10 2023

“Sometimes, the work of your male colleague is valued more than your own because you are a woman”

“Female talent, scientists speak” is an IDIBAPS campaign that seeks to give visibility to female researchers and to reflect on the obstacles they fac1

Clínic Barcelona

Institutional February 9 2023

“Having female role models in science motivates me to choose a scientific career and helps me to feel sure about my decision”

As part of the International Day of Women and Girls in Science 2023, groups of between three and four secondary school students interested in biomedi1

Clínic Barcelona

Institutional February 3 2023

Volunteers from the Spanish Association Against Cancer visit IDIBAPS

On the occasion of World Cancer Day, to be held next Saturday, February 4, IDIBAPS, together with the AECC, has organized three meetings between volu1

Clínic Barcelona

Research November 11 2021

The AECC awards Hospital Clínic-IDIBAPS 2.1 million euros for cancer research

On Thursday, 11 November, the Spanish Cancer Association (AECC) awarded the AECC 2021 Grants for Cancer Research at an event held at the organization1

Clínic Barcelona

Research March 29 2021

A molecular classification predicts the prognosis and the benefit of a cell cycle inhibitor in metastatic breast cancer

In a study published in the Journal of Clinical Oncology, researchers from the Hospital Clínic-IDIBAPS-UB and SOLTI showed the predictive capacity of1

News about Fara Brasó-Maristany

“Sometimes, the work of your male colleague is valued more than your own because you are a woman”

“Having female role models in science motivates me to choose a scientific career and helps me to feel sure about my decision”

Volunteers from the Spanish Association Against Cancer visit IDIBAPS

The AECC awards Hospital Clínic-IDIBAPS 2.1 million euros for cancer research

A molecular classification predicts the prognosis and the benefit of a cell cycle inhibitor in metastatic breast cancer

Subscribe to the Newsletter of Clínic